Jazz Pharmaceuticals (JAZZ) Interest Expenses (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Interest Expenses of $578.5 million for Q1 2026, down 8.27% year-over-year from $630.7 million in Q1 2025, and up 1748.24% quarter-over-quarter from $31.3 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Interest Expenses (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Interest Expenses history runs 17 years deep, the most recent figure standing at $578.5 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 8.27% year-over-year to $578.5 million; the TTM figure through Mar 2026 stood at $578.5 million (down 8.27% YoY), while the FY2025 annual figure was $647.3 million, up 27.12% from the prior year.
- Interest Expenses for Q1 2026 stood at $578.5 million, up from $31.3 million in the prior quarter.
- The five-year high for Interest Expenses was $647.1 million in Q3 2024, with the low at $8.6 million in Q2 2024.
- The 5-year median for Interest Expenses is $602.4 million (2023), against an average of $470.0 million.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses sank 98.61% in 2024, then soared 7398.91% in 2025.
- Jazz Pharmaceuticals' Interest Expenses stood at $25.2 million in 2022, then jumped by 1155.21% to $316.3 million in 2023, then fell by 1.2% to $312.5 million in 2024, then slumped by 89.98% to $31.3 million in 2025, then jumped by 1748.24% to $578.5 million in 2026.
- Business Quant data shows JAZZ's Interest Expenses at $578.5 million in Q1 2026, $31.3 million in Q4 2025, and $638.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 577.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 577.80 Mn |
| Jun 30, 2026 | 577.80 Mn |
| Mar 31, 2026 | 578.50 Mn |
| Mar 31, 2026 | 578.50 Mn |
| Dec 31, 2025 | 31.30 Mn |
| Dec 31, 2025 | 31.30 Mn |
| Sep 30, 2025 | 638.42 Mn |
| Sep 30, 2025 | 638.42 Mn |
| Jun 30, 2025 | 644.91 Mn |
| Jun 30, 2025 | 644.91 Mn |
| Mar 31, 2025 | 630.66 Mn |
| Mar 31, 2025 | 630.66 Mn |
| Dec 31, 2024 | 312.52 Mn |
| Dec 31, 2024 | 312.52 Mn |
| Sep 30, 2024 | 647.10 Mn |
| Sep 30, 2024 | 647.10 Mn |
| Jun 30, 2024 | 8.60 Mn |
| Jun 30, 2024 | 8.60 Mn |
| Mar 31, 2024 | 620.01 Mn |
| Mar 31, 2024 | 620.01 Mn |